|
Prior to his affiliation with the University and the Institute, Dr. Davis spent 20 years in the United States Army. From 1986 to 1988, he served as Chief of Infectious Disease and Infection Control at William Beaumont Army Medical Center in El Paso, TX. In 1988, he received the Mayor's Award from that city for his work with HIV. From 1989 to 1990, Dr. Davis served as Chief of Infection Control at the Walter Reed Army Medical Center in Washington D.C. For five years he was a principal investigator in the HIV Immunotherapy Research Program at the Wilford Hall Air Force Medical Center in San Antonio.
In addition to his teaching responsibilities, Dr. Davis manages the clinical research unit located in the Institute of Human Virology. His current clinical trials include Phase I/II evaluation of potential vaccine candidates for HIV immunotherapy and Phase I clinical trials of a natural product found in the skin of red grapes, which augments the suppressive activity of HIV-1 in vitro. His overall research interests include immunotherapy for the treatment of HIV, cell-cycle modification to control HIV replication and as an adjunct to augment the activity of nucleoside analogues in the treatment of HIV, and complementary therapy for HIV treatment.
Dr. Davis has authored four book chapters and more than a dozen articles-a body of work that focuses not only on HIV but a variety of other infectious diseases. In August 2002, he was awarded a patent for Resveratrol as an antiviral potentiator.
Dr. Davis began his studies at Virginia State University and received his M.D. from the Medical College of Virginia in 1978. His medical internship, residency, and fellowship were all completed while serving in the U.S. Army where he was awarded the Meritorious Service Medal three times.
|
